- Our Doctors
- Dr Kamalalram Thippu Jayaprakash
Dr Kamalram Thippu Jayaprakash
MBBS, MSc Oncology, MD RT, MD, MRCP (UK), FRCR, Clinical Oncologist
Languages spoken
English
Overview
Centres
Specialises in
Dr Thippu is a Consultant Clinical Oncologist based in Cambridge UK and Affiliated Assistant Professor at the Department of Oncology, University of Cambridge. He specialises in lung, prostate, bladder and oligometastatic cancers.
Dr Thippu trained in Clinical Oncology at Cambridge and completed an MSc Oncology at the Institute of Cancer Research, London. During his doctoral research fellowship, he investigated radiosensitising strategies in-vitro, and was awarded an MD. He completed proton beam therapy at the Paul Scherrer Institute in Switzerland and SRS fellowships.
His wide-ranging research interests including technical radiotherapy, late-phase radiotherapy trials and AI in radiation oncology. A member of many trial development/management groups and a site principal investigator of several studies, Dr Thippu has also authored numerous scientific papers and book chapters, written guidelines and presented at many conferences.
Dr Thippu is an educator and mentor for oncology residents and medical students, and Assistant Editor of Clinical Oncology journal.
Expertise and interests
Clinical trials, artificial intelligence in radiotherapy
- Radiotherapy
- SABR/SBRT
- Targeted therapies
- Chemotherapy
- Immunotherapy
Professional association
- Affiliated Assistant Professor, Department of Oncology, University of Cambridge
- Royal College of Radiologists, European Society for Radiotherapy and Oncology
Publications & affiliations
- Shor D, Khoo V, Jayaprakash KT. Advancing the Paradigm: Oligometastatic Disease and the Impact of Stereotactic Ablative Body Radiotherapy. Clin Oncol (R Coll Radiol). 2024 Jul;36(7):402-405. doi: 10.1016/j.clon.2024.03.023. Epub 2024 Mar 26. PMID: 38631977
- Greenwood H, Hassan J, Fife K, Ajithkumar TV, Thippu Jayaprakash K. Single-Fraction Stereotactic Ablative Body Radiotherapy for Primary and Extracranial Oligometastatic Cancers. Clin Oncol (R Coll Radiol). 2023 Dec;35(12):773-786. doi: 10.1016/j.clon.2023.10.049. Epub 2023 Oct 10. PMID: 37852814
- Crockett C, Salem A, Thippu Jayaprakash K. Shooting the Star: Mitigating Respiratory Motion in Lung Cancer Radiotherapy. Clin Oncol (R Coll Radiol). 2022 Mar;34(3):160-163. doi: 10.1016/j.clon.2021.11.017. Epub 2021 Dec 7. PMID: 34893390
- Thippu Jayaprakash K, Hussein M, Shaffer R, Michael A, Nisbet A, Ajaz M. In Vitro Evaluation of Notch Inhibition to Enhance Efficacy of Radiation Therapy in Melanoma. Adv Radiat Oncol. 2020 Nov 25;6(2):100622. doi: 10.1016/j.adro.2020.11.007. PMID: 33732959; PMCID: PMC7940786
- Connor MJ, Shah TT, Smigielska K, Day E, Sukumar J, Fiorentino F, Sarwar N, Gonzalez M, Falconer A, Klimowska-Nassar N, Evans M, Naismith OF, Thippu Jayaprakash K, Price D, Gayadeen S, Basak D, Horan G, McGrath J, Sheehan D, Kumar M, Ibrahim A, Brock C, Pearson RA, Anyamene N, Heath C, Shergill I, Rai B, Hellawell G, McCracken S, Khoubehi B, Mangar S, Khoo V, Dudderidge T, Staffurth JN, Winkler M, Ahmed HU. Additional Treatments to the Local tumour for metastatic prostate cancer-Assessment of Novel Treatment Algorithms (IP2-ATLANTA): protocol for a multicentre, phase II randomised controlled trial. BMJ Open. 2021 Feb 25;11(2):e042953. doi: 10.1136/bmjopen-2020-042953. PMID: 33632752; PMCID: PMC7908915
Make a booking
We’re recognised by all private medical providers, including Bupa, AXA PPP, Aviva and Vitality. We’re always happy to answer any questions and concerns you may have.
Thank you for your enquiry.
We'll be in touch during our next working day (Monday to Friday, except for bank holidays)
Form submission error
There was an error submitting this form. Please refresh your screen and try again. If this error persists, please email contactus@genesiscare.co.uk for assistance.